Authors:
Chiappetta, G
Manfioletti, G
Pentimalli, F
Abe, N
Di Bonito, M
Vento, MT
Giuliano, A
Fedele, M
Viglietto, G
Santoro, M
Watanabe, T
Giancotti, V
Fusco, A
Citation: G. Chiappetta et al., High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases, INT J CANC, 91(2), 2001, pp. 147-151
Authors:
Frasci, G
D'Aiuto, G
Comella, P
Thomas, R
Capasso, I
Di Bonito, M
Rivellini, F
Carteni, G
De Lucia, L
Maiorino, L
D'Aniello, R
Frezza, P
Lapenta, L
Comella, G
Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study, BREAST CANC, 62(2), 2000, pp. 87-97
Authors:
Acampora, D
Postiglione, MP
Avantaggiato, V
Di Bonito, M
Vaccarino, FM
Michaud, J
Simeone, A
Citation: D. Acampora et al., Progressive impairment of developing neuroendocrine cell lineages in the hypothalamus of mice lacking the Orthopedia gene, GENE DEV, 13(21), 1999, pp. 2787-2800
Authors:
Frasci, G
D'Aiuto, G
Comella, P
Apicella, A
Thomas, R
Capasso, I
Di Bonito, M
Carteni, G
Biglietto, M
Lucia, LD
Maiorino, L
Piccolo, S
Bianchi, U
D'Aniello, R
Lapenta, L
Comella, G
Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group, BREAST CANC, 56(3), 1999, pp. 239-252